OmicsChart IOBE

is a platform with a collection of all published biomarkers in immuno-oncology

features

Contrary to popular belief, Lorem Ipsum is not simply random text

State-of-the-art

Many desktop publishing packages and web page editors now use Lorem Ipsum as their default model text, and a search for

Decision support

Many desktop publishing packages and web page editors now use Lorem Ipsum as their default model text, and a search for

Comprehensive

Many desktop publishing packages and web page editors now use Lorem Ipsum as their default model text, and a search for

about omicschart iobe

It will allow the user to search by publication name or by keyword, and will provide a detailed description of the biomarker, reference to the publication, evaluation methods and relevant gene lists.

Desription for images
Desription for images

It will also extract the information about ongoing trials where the given biomarker is used. The user will also be able to request addition of a biomarker to the encyclopedia via a feedback form, by providing a publication.

It will also be possible to evaluate each biomarker in TCGA, as well as upload one's own sample into IOBE and evaluate the given biomarker in the sample for an additional fee.

Motivation The composition and density of immune cells in the tumor microenvironment profoundly influence tumor progression and success of anti-cancer therapies. Flow cytometry, immunohistochemistry staining, or single-cell sequencing is often unavailable such that we rely on computational methods to estimate the immune-cell composition from bulk RNA-sequencing (RNA-seq) data. Various methods have been proposed recently, yet their capabilities and limitations have not been evaluated systematically. A general guideline leading the research community through cell type deconvolution is missing.

There are many variations of passages of Lorem Ipsum available, but the majority have suffered alteration in some form, by injected humour, or randomised words which don't look even slightly believable. If you are going to use a passage of Lorem Ipsum, you need to be sure there isn't anything embarrassing hidden in the middle of text. All the Lorem Ipsum generators on the Internet tend to repeat predefined chunks as necessary, making this the first true generator on the Internet. It uses a dictionary of over 200 Latin words, combined with a handful of model sentence structures, to generate Lorem Ipsum which looks reasonable. The generated Lorem Ipsum is therefore always free from repetition, injected humour, or non-characteristic words etc.

OmicsChart IOBE

is a platform with a collection of all published biomarkers in immuno-oncology

more product

We provide free access to two submodules of OmicsChart IO:

OmicsChart IO

Biomarker Data Software Platform

Browse The Cancer Genome Atlas using our convenint interface, explore matation and expression data, estimation of infiltration by immune cells in solid tumors, or correlate any of the above to each other

OmicsChart Neopep

Individual Patient Sequencing Data

Look up any biomarker from published literature, see in which clinical trials it was used, and even upload your own sample to estimate this biomarker and compare it to TCGA samples.